You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

~ Buy the STARCH, PREGELATINIZED CORN Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Drugs Containing Excipient (Inactive Ingredient) STARCH, PREGELATINIZED CORN


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing STARCH, PREGELATINIZED CORN excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing STARCH, PREGELATINIZED CORN excipient

STARCH, PREGELATINIZED CORN Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Pregelatinized Corn Starch as a Pharmaceutical Excipient

Introduction

Pregelatinized corn starch, a modified starch that has been pre-cooked and dried, is increasingly important in various industries, including the pharmaceutical sector. This article delves into the market dynamics and financial trajectory of pregelatinized corn starch, highlighting its growth drivers, market segmentation, and future outlook.

Market Size and Growth

The pregelatinized starch market, which includes pregelatinized corn starch, has shown robust growth in recent years. As of 2023, the global pregelatinized starch market was valued at approximately $1.93 billion and is expected to grow to $2.31 billion by 2028 at a compound annual growth rate (CAGR) of 4.6%[1][4].

Market Segmentation

The pregelatinized starch market is segmented based on several criteria:

By Source

  • Corn is the dominant source, accounting for about 43.1% of the global market in 2023 due to its widespread availability, cost-effectiveness, and excellent functional properties[4].

By Form

  • Pregelatinized starch is available in flake and powder forms, each catering to different application needs[1].

By Application

  • The pharmaceutical industry is one of the key applications, alongside the food and beverage, chemical, cosmetics, and other industries[1].

Drivers of Growth

Several factors are driving the growth of the pregelatinized corn starch market:

Increasing Demand for Convenience Foods

The rising preference for ready-to-eat and easy-to-prepare food products has indirectly boosted the demand for pregelatinized starch, as it is used to enhance texture, stability, and shelf-life in these products. This trend is expected to continue, benefiting the pharmaceutical sector where similar convenience and stability are valued[4].

Technological Advancements

Innovations in food processing technologies, such as extrusion and spray drying, have improved the functional properties of pregelatinized starch. These advancements enable the production of starch with specific properties tailored to meet the requirements of different industries, including pharmaceuticals[4].

Preference for Natural and Sustainable Ingredients

There is a growing focus on sustainable and natural ingredients across various industries. Pregelatinized corn starch, derived from natural sources, aligns well with this trend, offering a sustainable and eco-friendly alternative to synthetic additives. This shift is supported by regulatory initiatives promoting the use of natural ingredients[4].

Expansion into Emerging Markets

The Asia-Pacific region, particularly countries like China, India, and Japan, is witnessing significant growth in the food and pharmaceutical sectors. This expansion is driving the demand for pregelatinized corn starch in these regions[4].

Pharmaceutical Industry Specifics

In the pharmaceutical industry, pregelatinized corn starch is valued for its properties as an excipient:

Improved Tablet Disintegration

Pregelatinized corn starch is often used as a disintegrant in tablet formulations, helping to break down the tablet quickly and efficiently once ingested[4].

Enhanced Stability

Its pre-cooked and dried form ensures stability and consistency in pharmaceutical products, which is crucial for maintaining the efficacy and shelf-life of medications[4].

Cost-Effectiveness

Compared to other excipients, pregelatinized corn starch is cost-effective, making it an attractive option for pharmaceutical manufacturers looking to optimize production costs without compromising on quality[1].

Financial Trajectory

The financial outlook for the pregelatinized corn starch market is promising:

Current Market Value

As of 2023, the global pregelatinized starch market, which includes corn starch, was valued at $1.93 billion[1].

Forecasted Growth

The market is expected to grow to $2.31 billion by 2028 at a CAGR of 4.6%. This growth is driven by increasing demand in various industries, including the pharmaceutical sector[1].

Regional Insights

North America currently represents the largest market for pregelatinized starch in value terms, driven by the high demand for convenience foods and advanced food processing technologies. However, the Asia-Pacific region is expected to witness the highest growth rate due to expanding food and pharmaceutical industries[4].

Key Trends and Innovations

Several trends and innovations are shaping the future of the pregelatinized corn starch market:

Technological Advancements

Continuous improvements in processing technologies are enhancing the functional properties of pregelatinized starch, making it more versatile and effective in various applications[4].

Customization and Functional Innovation

Manufacturers are focusing on producing pregelatinized starch with specific properties tailored to meet the unique requirements of different industries, including pharmaceuticals[1].

Sustainable Sourcing and Production

The emphasis on sustainable sourcing and production practices is expected to continue, driven by consumer demand and regulatory support for eco-friendly and biodegradable ingredients[4].

Regulatory Support

Regulatory bodies worldwide are encouraging the use of natural, safe, and non-toxic ingredients. This regulatory push, combined with consumer awareness, is driving the adoption of pregelatinized corn starch across various applications, including pharmaceuticals.

"Governments and regulatory bodies worldwide are encouraging the use of natural, safe, and non-toxic ingredients, which has led to an increased adoption of pregelatinized starch across various applications."[4]

Geographical Insights

  • North America: Represents the largest market in value terms due to high demand for convenience foods and advanced food processing technologies.
  • Asia-Pacific: Expected to witness the highest growth rate due to increasing population, rising disposable incomes, and expanding food and pharmaceutical industries.
  • Europe: Driven by strong demand for convenience foods, pharmaceuticals, and cosmetics, with a focus on sustainable and natural ingredients[4].

Key Takeaways

  • The pregelatinized corn starch market is driven by increasing demand for convenience foods, technological advancements, and a preference for natural and sustainable ingredients.
  • The market is expected to grow from $1.93 billion in 2023 to $2.31 billion by 2028 at a CAGR of 4.6%.
  • The pharmaceutical industry benefits from pregelatinized corn starch due to its properties as a disintegrant and stabilizer.
  • Regulatory support and consumer awareness are key factors driving the adoption of pregelatinized corn starch.

FAQs

Q: What is the current market size of the pregelatinized starch market? A: As of 2023, the global pregelatinized starch market was valued at approximately $1.93 billion[1].

Q: What are the primary drivers of the pregelatinized corn starch market? A: The primary drivers include increasing demand for convenience foods, technological advancements in food processing, and a preference for natural and sustainable ingredients[4].

Q: Which region is expected to witness the highest growth rate in the pregelatinized starch market? A: The Asia-Pacific region is expected to witness the highest growth rate due to increasing population, rising disposable incomes, and expanding food and pharmaceutical industries[4].

Q: How is pregelatinized corn starch used in the pharmaceutical industry? A: Pregelatinized corn starch is used as a disintegrant and stabilizer in pharmaceutical products, enhancing tablet disintegration and stability[4].

Q: What is the forecasted market value of the pregelatinized starch market by 2028? A: The market is expected to grow to $2.31 billion by 2028 at a CAGR of 4.6%[1].

Sources

  1. The Business Research Company, "Pregelatinized Starch Global Market Report 2024, Opportunities And Analysis"
  2. GlobeNewswire, "Global Corn Starch Market Analysis Report 2024: A $40+ Billion Industry by 2032"
  3. GIIR Research, "Global Pregelatinized Starch Market Size, Share, Growth Analysis"
  4. GlobeNewswire, "Pregelatinized Starch Research Report 2024-2025 & 2030: Natural Ingredient Demand and Tech Advancements Push Market Growth Across Multiple Industries"

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.